Lisata Historical Balance Sheet

LSTA Stock  USD 2.62  0.04  1.55%   
Trend analysis of Lisata Therapeutics balance sheet accounts such as Total Current Liabilities of 8.5 M provides information on Lisata Therapeutics' total assets, liabilities, and equity, which is the actual value of Lisata Therapeutics to its prevalent stockholders. By breaking down trends over time using Lisata Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Lisata Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lisata Therapeutics is a good buy for the upcoming year.

Lisata Therapeutics Inventory

4.54 Million

  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lisata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.

About Lisata Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Lisata Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Lisata Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lisata Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lisata currently owns. An asset can also be divided into two categories, current and non-current.

Lisata Therapeutics Balance Sheet Chart

At present, Lisata Therapeutics' Total Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 50.6 M, whereas Total Assets are forecasted to decline to about 43.4 M.

Total Current Liabilities

Total Current Liabilities is an item on Lisata Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Lisata Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most accounts from Lisata Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Lisata Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lisata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.At present, Lisata Therapeutics' Total Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 50.6 M, whereas Total Assets are forecasted to decline to about 43.4 M.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total714K485K305K289.8K
Total Assets97.0M73.0M54.7M43.4M

Lisata Therapeutics balance sheet Correlations

0.350.680.680.70.46-0.020.120.50.810.12-0.110.720.37-0.020.750.380.270.190.650.630.190.110.630.010.1
0.350.090.52-0.130.830.450.220.810.560.79-0.380.70.71-0.230.68-0.320.70.170.010.65-0.02-0.390.55-0.220.66
0.680.090.860.210.310.290.320.070.73-0.11-0.20.520.14-0.270.68-0.010.430.280.970.19-0.28-0.320.13-0.28-0.13
0.680.520.860.040.710.430.30.50.840.33-0.310.760.46-0.280.89-0.190.760.30.790.4-0.23-0.480.34-0.330.26
0.7-0.130.210.04-0.14-0.55-0.30.120.2-0.270.360.080.00.430.070.87-0.32-0.080.220.230.550.740.390.47-0.11
0.460.830.310.71-0.140.330.340.830.710.72-0.480.810.59-0.350.82-0.370.840.30.230.60.03-0.50.48-0.340.52
-0.020.450.290.43-0.550.330.480.090.410.35-0.410.410.25-0.540.44-0.690.580.470.330.27-0.9-0.750.08-0.380.11
0.120.220.320.3-0.30.340.48-0.070.50.09-0.660.4-0.14-0.990.39-0.620.340.740.390.37-0.44-0.690.02-0.66-0.48
0.50.810.070.50.120.830.09-0.070.550.81-0.060.740.820.080.69-0.030.55-0.04-0.020.670.3-0.120.69-0.090.69
0.810.560.730.840.20.710.410.50.550.36-0.410.920.42-0.450.95-0.220.580.440.730.78-0.19-0.480.66-0.490.07
0.120.79-0.110.33-0.270.720.350.090.810.36-0.10.60.74-0.10.53-0.320.49-0.07-0.160.50.0-0.340.48-0.210.6
-0.11-0.38-0.2-0.310.36-0.48-0.41-0.66-0.06-0.41-0.1-0.430.170.72-0.430.55-0.45-0.4-0.19-0.330.30.58-0.020.4-0.06
0.720.70.520.760.080.810.410.40.740.920.6-0.430.6-0.370.97-0.250.570.230.480.85-0.12-0.460.73-0.420.33
0.370.710.140.460.00.590.25-0.140.820.420.740.170.60.120.58-0.040.44-0.180.050.470.06-0.150.47-0.020.66
-0.02-0.23-0.27-0.280.43-0.35-0.54-0.990.08-0.45-0.10.72-0.370.12-0.370.71-0.38-0.71-0.34-0.310.50.760.060.680.41
0.750.680.680.890.070.820.440.390.690.950.53-0.430.970.58-0.37-0.240.680.280.620.73-0.17-0.490.62-0.410.32
0.38-0.32-0.01-0.190.87-0.37-0.69-0.62-0.03-0.22-0.320.55-0.25-0.040.71-0.24-0.48-0.4-0.05-0.170.620.950.060.770.04
0.270.70.430.76-0.320.840.580.340.550.580.49-0.450.570.44-0.380.68-0.480.510.360.28-0.32-0.620.15-0.260.44
0.190.170.280.3-0.080.30.470.74-0.040.44-0.07-0.40.23-0.18-0.710.28-0.40.510.390.26-0.46-0.480.02-0.34-0.42
0.650.010.970.790.220.230.330.39-0.020.73-0.16-0.190.480.05-0.340.62-0.050.360.390.2-0.37-0.350.12-0.33-0.29
0.630.650.190.40.230.60.270.370.670.780.5-0.330.850.47-0.310.73-0.170.280.260.20.02-0.280.91-0.420.17
0.19-0.02-0.28-0.230.550.03-0.9-0.440.3-0.190.00.3-0.120.060.5-0.170.62-0.32-0.46-0.370.020.660.190.310.19
0.11-0.39-0.32-0.480.74-0.5-0.75-0.69-0.12-0.48-0.340.58-0.46-0.150.76-0.490.95-0.62-0.48-0.35-0.280.66-0.040.820.05
0.630.550.130.340.390.480.080.020.690.660.48-0.020.730.470.060.620.060.150.020.120.910.19-0.04-0.260.27
0.01-0.22-0.28-0.330.47-0.34-0.38-0.66-0.09-0.49-0.210.4-0.42-0.020.68-0.410.77-0.26-0.34-0.33-0.420.310.82-0.260.31
0.10.66-0.130.26-0.110.520.11-0.480.690.070.6-0.060.330.660.410.320.040.44-0.42-0.290.170.190.050.270.31
Click cells to compare fundamentals

Lisata Therapeutics Account Relationship Matchups

Lisata Therapeutics balance sheet Accounts

201920202021202220232024 (projected)
Total Assets27.2M36.0M97.0M73.0M54.7M43.4M
Other Current Liab1.6M2.1M2.4M3.5M4.0M3.4M
Total Current Liabilities6.0M3.5M4.5M6.4M6.6M8.5M
Total Stockholder Equity20.8M32.5M92.3M66.6M48.1M50.6M
Property Plant And Equipment Net100K57K62K296K483K458.9K
Net Debt(13.7M)(15.9M)(23.9M)(31.7M)(22.3M)(21.2M)
Retained Earnings(417.4M)(425.6M)(453.0M)(507.2M)(528.1M)(501.7M)
Accounts Payable1.5M1.0M1.9M2.7M2.4M2.4M
Non Current Assets Total1.2M671K826K1.2M770K731.5K
Common Stock Shares Outstanding688.3K1.0M3.7M5.2M8.1M8.5M
Liabilities And Stockholders Equity27.2M36.0M97.0M73.0M54.7M43.4M
Non Current Liabilities Total624K254K485K327K210K199.5K
Other Current Assets815K758K1.2M2.7M3.4M1.7M
Other Stockholder Equity438.2M458.0M545.3M573.8M576.3M605.1M
Total Liab6.6M3.8M5.0M6.7M6.8M6.5M
Total Current Assets26.0M35.3M96.2M71.9M53.9M56.6M
Accumulated Other Comprehensive Income2K(13K)(70K)(29K)(42K)(44.1K)
Common Stock11K19K60K8K7.2K6.8K
Non Currrent Assets Other1.1M614K764K528K24K22.8K
Cash14.0M16.5M24.6M32.2M22.6M23.7M
Cash And Short Term Investments25.2M34.6M95.0M69.2M50.5M53.1M
Short Term Investments11.1M18.1M70.3M37.1M27.9M18.7M
Other Assets309K0.040K1.2M1.4M1.5M
Net Invested Capital20.8M32.5M92.3M66.6M48.1M54.6M
Capital Stock11K19K60K8K9.2K8.7K
Net Working Capital20.0M31.8M91.7M65.5M47.3M54.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Lisata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lisata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lisata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lisata Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lisata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lisata Therapeutics. If investors know Lisata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lisata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.51)
Return On Assets
(0.29)
Return On Equity
(0.44)
The market value of Lisata Therapeutics is measured differently than its book value, which is the value of Lisata that is recorded on the company's balance sheet. Investors also form their own opinion of Lisata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lisata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lisata Therapeutics' market value can be influenced by many factors that don't directly affect Lisata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lisata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lisata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lisata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.